SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors digest news of its upcoming Russell 3000 index inclusion and a high-profile partnership with the U.S. Army to develop domestic heavy rare earth processing facilities. While the community is actively debating the company's long-term potential as a defense industry supplier versus concerns over volatility and dilution, traders are closely watching for signs of a short squeeze amid high short interest and institutional accumulation.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh strong quarterly profitability and upgraded analyst outlooks against geopolitical instability and Middle East shipping disruptions. The community remains focused on the company's long-term production growth and institutional backing, while actively debating the impact of energy sector volatility on its current valuation.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors debate the impact of high short interest and institutional manipulation against the brand's long-term growth potential and distribution partnership with Pepsi. The community is actively discussing the stock's recent volatility, comparing its performance to competitors like Monster, and speculating on the potential for a massive squeeze or buyout.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is seeing heightened investor attention as community members debate the timing of clinical trial catalysts and the potential for a strategic partnership, while some traders closely monitor the company's pending financial filings and ongoing volatility. Enthusiasts are focusing on the company's recent operational updates and the broader implications of its immunotherapy trial, while others remain cautious and continue to analyze the stock's tight float and the impact of short-selling pressure.

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

NextNav is trending as shareholders anticipate an upcoming FCC Notice of Proposed Rulemaking (NPRM) regarding the company's spectrum rights, with active community discussion centered on potential national security catalysts and the impact of significant liquidity events like warrant redemptions. Investors are debating the timing of FCC agenda announcements and the influence of heavy institutional positioning against a backdrop of ongoing regulatory hurdles.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors prepare for an upcoming FDA advisory committee meeting and PDUFA date for its Duchenne muscular dystrophy therapy, Deramiocel. The stock faces volatility driven by community debate over the strength of clinical data, patent litigation, and institutional accumulation, with bulls emphasizing strong Phase 3 results as the primary catalyst for a potential rally.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant downward pressure as investors navigate the recent integration of TopBuild and lingering concerns over share dilution, while the community remains divided between long-term bulls betting on Brad Jacobs' track record and frustrated traders wary of continued selling. The stock is a focal point of intense discussion as market participants debate whether the current price action represents a forced liquidation by arbitrageurs or a more fundamental long-term challenge.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk Corp is seeing extreme volatility as market participants debate whether recent massive pullbacks represent a genuine buying opportunity or a deeper correction fueled by institutional liquidation. The stock remains a focal point for intense sentiment clashes, with traders divided between betting on a sharp relief bounce and warning of further downside pressure amid broader semiconductor sector jitters.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending as investors reassess the company's growth trajectory following a significant stock price pullback. While the company continues to demonstrate strong fundamentals and a dominant market position, the community is debating whether the current price action reflects a temporary valuation reset or a long-term shift in growth expectations.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle is trending due to a surge in investor confidence driven by rebounding lithium prices, strong demand for battery energy storage, and strategic supply chain shifts. The community is actively discussing its momentum, with many highlighting potential breakouts and long-term recovery prospects as the company benefits from both increased EV adoption and energy infrastructure needs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2026 financial results after the market closes on Thursday, August 6, 2026. On the same day, the Company will host a...

Inogen Announces the Appointment of Andy Reding as Chief Operating Officer

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Andy Reding to the newly created role of Chief Operating Officer, effective Monday, July 6, 2026. Mr. Reding will be responsible for...

Here's Why You Should Retain Inogen Stock in Your Portfolio for Now

INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk.

INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel shifts.

INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves

Inogen posts higher Q1 revenues and improved gross margin as international portable oxygen demand offsets weaker U.S. sales.

Inogen (INGN) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of -25.00% and +3.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Inogen Announces First Quarter 2026 Financial Results

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2026 and reiterated its full-year guidance. Our first quarter revenue exceeded our outlook with...

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of +5.88% and +0.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Inogen (INGN) Projected to Post Earnings on Thursday

Inogen (NASDAQ:INGN) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-inogen-inc-stock...

Inogen, Inc. is a global medical technology company offering innovative respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Beverly, MA.

Inogen Inc

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$6.57
Prev Close	$6.66
Open	$6.60
Dividend Yield	0.00%
50-Day Moving Average	$6.54
Beta	1.13
Avg. Volume	339,756.87
PE Ratio	-7.27

52-Week High	$9.13
52-Week Low	$5.34
Market Capitalization	$180.32M
EPS (Annual)	-$0.8551
Price to Book	1.00
Revenue Per Employee	$463,038.51

Feed

News

Sentiment

Earnings

Fundamentals

Info

INGNInogen Inc

Latest INGN News